These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10938955)

  • 1. The use of riboflavin for the inactivation of pathogens in blood products.
    Goodrich RP
    Vox Sang; 2000; 78 Suppl 2():211-5. PubMed ID: 10938955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.
    Ruane PH; Edrich R; Gampp D; Keil SD; Leonard RL; Goodrich RP
    Transfusion; 2004 Jun; 44(6):877-85. PubMed ID: 15157255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogen-reduction systems for blood components: the current position and future trends.
    Seghatchian J; de Sousa G
    Transfus Apher Sci; 2006 Dec; 35(3):189-96. PubMed ID: 17110168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
    Reddy HL; Dayan AD; Cavagnaro J; Gad S; Li J; Goodrich RP
    Transfus Med Rev; 2008 Apr; 22(2):133-53. PubMed ID: 18353253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Rentas FJ; Ketchum L; Salata J; Harman R; Melvin W; Weina PJ; Mendez J; Reddy H; Goodrich R
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.
    Li J; de Korte D; Woolum MD; Ruane PH; Keil SD; Lockerbie O; McLean R; Goodrich RP
    Vox Sang; 2004 Aug; 87(2):82-90. PubMed ID: 15355498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.
    Janetzko K; Lin L; Eichler H; Mayaudon V; Flament J; Klüter H
    Vox Sang; 2004 May; 86(4):239-45. PubMed ID: 15144528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology.
    Hardwick CC; Herivel TR; Hernandez SC; Ruane PH; Goodrich RP
    Photochem Photobiol; 2004; 80(3):609-15. PubMed ID: 15382964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen inactivation of blood components: current status and introduction of an approach using riboflavin as a photosensitizer.
    Corbin F
    Int J Hematol; 2002 Aug; 76 Suppl 2():253-7. PubMed ID: 12430933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ; Salata J; Mendez J; Reddy H; Goodrich R
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
    AuBuchon JP; Herschel L; Roger J; Taylor H; Whitley P; Li J; Edrich R; Goodrich RP
    Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.
    Goodrich RP; Gilmour D; Hovenga N; Keil SD
    Transfusion; 2009 Jun; 49(6):1205-16. PubMed ID: 19320867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Orientia tsutsugamushi in red blood cells, plasma, and platelets with riboflavin and light, as demonstrated in an animal model.
    Rentas F; Harman R; Gomez C; Salata J; Childs J; Silva T; Lippert L; Montgomery J; Richards A; Chan C; Jiang J; Reddy H; Li J; Goodrich R
    Transfusion; 2007 Feb; 47(2):240-7. PubMed ID: 17302769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J; Rock G
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects.
    Goodrich RP; Li J; Pieters H; Crookes R; Roodt J; Heyns Adu P
    Vox Sang; 2006 May; 90(4):279-85. PubMed ID: 16635070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogen reduction of blood components.
    Solheim BG
    Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet function assessed by shear-induced deposition of split triple-dose apheresis concentrates treated with pathogen reduction technologies.
    Picker SM; Schneider V; Gathof BS
    Transfusion; 2009 Jun; 49(6):1224-32. PubMed ID: 19220821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.